Ra-223 dichloride
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Ra-223 dichloride, covering 2021-02-02 to 2021-10-07. Get the full timeline:
Most recent: Clinical Trial Update: Trial of Ra-223 Dichloride in Combination With Hormonal Therapy and Denosumab in the Treatment of Patients With Hormone-Positive Bone-Dominant Metastatic Breast Cancer [Phase 2]